// App-Quantinova.ai

P469 : Infliximab for induction of medically-induced remission in Crohn's disease: a Cochrane systematic review

Researchers

Presenter

  • Radford, S

Principal Investigators

  • Sinopoulou, V

  • Gordon, M

  • Eldragini, M.E.A.A

  • Darie, A.M

  • Akobeng, A

  • Moran, G.W

Medical Centers

  • Nottingham University Hospitals NHS Trust, NIHR Nottingham Biomedical Research Centre - Gastrointestinal and Liver disorders theme, Nottingham, United Kingdom

  • UCLan, School of Medicine, Preston, United Kingdom

  • Sidra Medicine, Medicine, Doha, Qatar

Locations

  • United Kingdom

  • Qatar

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Active Comparator

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved